Middlebrook Pharmaceuticals (MBRK) Obtains 100M Investment for Commercialization of MOXATAGä
Source: http://Blog.QualityStocks.net/?p=10961Posted on Monday, July 7th, 2008 | In Current Market News, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Middlebrook Pharmaceuticals discovered in 2000 that bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens. The company went on to develop novel anti-infective pulsatile drug products that take advantage of this discovery.
Middlebrook is applying their technology to drugs that may have lost their effectiveness in previous applications. The advantages of pulse therapy are: once-a-day formulation, lower dosages, shorter duration of therapy, reduced side effects, reduced incidence of resistance, combination products with superior efficacy over either product alone, and improved pediatric and geriatric dosages.
The $100M investment in Middlebrook should be exciting for investors. However, some Middlebrook investors were hoping for an outright buyout at $6 to $8 dollars a share by a larger pharmaceutical. This investment shows that the company is viable, and that a serious investment company such as Equity Group Investments, LLC would not have moved forward or taken over leadership of the company had they not thought the products were commercially viable and able to return their $100M investment. The average expectation of a venture capitalist is a 20% return per year. This news should be taken well by stockholders, and for those who do not yet own Middlebrook, now may be the time to start watching the company more seriously.
Middlebrook is trading around $2.12 today on volume of 1.6M by 10 am. The 52-week spread for Middlebrook is $1.00 to $4.89. It appears the stock is climbing back up after the disappointing news of the investment instead of a buyout.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Stock Guru Featured Company: Quasar Aerospace Industries, Inc. (QASP.PK) - November 25th, 2009
- Stock Guru Featured Company: DecisionPoint Systems, Inc. (DNPI.OB) - November 25th, 2009
- Wake Forest Bancshares, Inc. (WAKE) Reports Profitable Fiscal Year - November 25th, 2009
- Rahaxi, Inc. (RXHI.OB) Reports Increase in Hardware Revenue and a Reduction in Quarterly Loss - November 25th, 2009
- NuEarth Corp. (NUEC.PK) Offering Clean Technologies and Products to meet Rising Environmentally Friendly Chemicals Demand - November 25th, 2009
6m, Antibiotic Treatment, Antibiotics, Bacteria, Combination Products, Commercialization, Current Market News, Discovery, duration, efficacy, expectation, Group Investments, Investment Company, investors, Middlebrook Pharmaceuticals, OTCBB Markets, Pulse Therapy, Pulses, resistance, Small & Micro Cap, stockholders, Stocks to Watch, Treatment Regimens, Venture Capitalist
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.